Olivier Adotévi

PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancer

Magalie Dosset, Thaiz Rivera Vargas, Anaïs Lagrange et al. · OncoImmunology · 2018 · 206 citations · Full text

A Decrease of Regulatory T Cells Correlates With Overall Survival After Sunitinib-based Antiangiogenic Therapy in Metastatic Renal Cancer Patients

Olivier Adotévi, Hélène Péré, Patrice Ravel et al. · Journal of Immunotherapy · 2010 · 201 citations

PD-L1 expression is regulated by both DNA methylation and NF-kB during EMT signaling in non-small cell lung carcinoma

Afag Asgarova, K. Asgarov, Yann Godet et al. · OncoImmunology · 2018 · 198 citations · Full text

A CCR4 antagonist combined with vaccines induces antigen-specific CD8+ T cells and tumor immunity against self antigens

Hélène Péré, Yves Montier, Jagadeesh Bayry et al. · Blood · 2011 · 155 citations · Full text

Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study

Stéfano Kim, Éric François, Thierry André et al. · The Lancet Oncology · 2018 · 140 citations

Gastrointestinal Oncology, Medicine, Metronomic Therapy +6